Johnson & Johnson is recognized as one of the Best Dividend Stocks for the Best Retirement Portfolio. Freedom Capital downgrades JNJ to Hold despite strong Q3 results, citing fair value estimate and US-China tariff uncertainties. JNJ’s revenue guidance boosted for the third time this year, driven by Oncology and Cardiovascular divisions.

Additionally, Johnson & Johnson plans to separate its Orthopedics division into an independent company to focus on faster-growing areas. JNJ is popular among income investors with a 63-year dividend growth streak and a 2.73% dividend yield. AI stocks offer greater upside potential and less downside risk compared to JNJ.

For more insights on investment opportunities, check out the best short-term AI stock.

Read more at Yahoo Finance: Freedom Capital Downgrades Johnson & Johnson (JNJ) to Hold Despite Strong Q3 Results